Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Special access opens for patients with muscle loss and obesity

NCT ID NCT06784297

TEMPORARILY_NOT_AVAILABLE Disease control Sponsor: Immunis, Inc. Source: ClinicalTrials.gov ↗

Summary

This program provides access to an experimental treatment for people with sarcopenic obesity (muscle loss combined with excess body fat) who cannot participate in regular clinical trials. It's designed for patients who don't qualify for other studies or can't travel to trial locations. Participants must meet specific criteria for both obesity and muscle weakness.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

Explore the condition pages connected to this study.